Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 11.7B | 11.7B | 11.2B | 11.0B |
Cost of revenue | 8.6B | 8.3B | 7.9B | 7.9B |
Gross profit | 3.2B | 3.4B | 3.3B | 3.1B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | 889M | 1.0B | 919M | 906M |
Operating income | 1.3B | 1.3B | 1.3B | 1.1B |
Non operating interest income | ||||
Income | 28M | 40M | — | 16M |
Expense | 73M | 104M | 101M | 64M |
Other income expense | — | — | — | — |
Pretax income | 1.2B | 1.2B | 1.2B | 1.1B |
Tax provision | 282M | 276M | 284M | 261M |
Net income | 934M | 928M | 871M | 809M |
Basic EPS | 3.6 | 3.6 | 3.4 | 3.1 |
Diluted EPS | 3.6 | 3.6 | 3.3 | 3.1 |
Basic average shares | 259.9M | 259.4M | 259.4M | 259.8M |
Diluted average shares | 260.6M | 260.8M | 261.0M | 260.6M |
EBITDA | 1.5B | 1.5B | 1.5B | 1.4B |
Net income from continuing op. | 1.3B | 1.3B | 1.3B | 1.1B |
Minority interests | -1M | -2M | -2M | -1M |
Preferred stock dividends | 0 | 0 | 0 | 0 |